Enniatin B (Synonyms: Antibiotic 86/88) |
Catalog No.GC17693 |
ionophore with some capacity to facilitate import of K+ and Na+ across membranes
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 917-13-5
Sample solution is provided at 25 µL, 10mM.
Enniatin B is an ionophore antibiotic.
Enniatins are one of the cyclohexadepsipeptides produced by various species of the genus Fusarium, and are reported to have antibiotic, ionophoric, and in-vitro hypolipidaemic activities.
In vitro: A non-toxic concentration of enniatin B could strongly inhibit a Pdr5p-mediated efflux of cycloheximide or cerulenin in Pdr5p-overexpressing cells. The mode of Pdr5p inhibition caused by enniatin B was competitive against FK506. However, enniatin B could not inhibit the function of Snq2p, a homologue of Pdr5p [1]. Another study showed that enniatin B was a relatively poor ionophore that could facilitate import of K+ and Na+ across membranes [2]. It was also found that like other enniatins, enniatin B was able to inhibit acyl-CoA: cholesterol acyltransferase [3].
In vivo: After oral administration to mice, no toxicological signs or pathological changes were observed. Moreover, enniatin B was found in all tissues and serum but not in urine, and the highest amounts was measured in liver and fat. Three phase I metabolites of enniatin B were found in liver and colon, with dioxygenated-enniatin B being most prominent [4].
Clinical trial: Up to now, enniatin B is still in the preclinical development stage.
References:
[1] K. Hiraga, S. Yamamoto, H. Fukuda, et al. Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. Biochemical and Biophysical Research Communications 328(4), 1119-1125 (2005).
[2] M. R. Kamyar, P. Rawnduzi, C. R. Studenik, et al. Investigation of the electrophysiological properties of enniatins. Archives of Biochemistry and Biophysics429(2), 215-223 (2004).
[3] Tomoda, X. H. Huang, J. Cao, et al. Inhibition of acyl-CoA: Cholesterol acyltransferase activity by cyclodepsipeptide antibiotics. J.Antibiot.(Tokyo) 45(10),1626-1632 (1992).
[4] Rodríguez-Carrasco Y et al. Mouse tissue distribution and persistence of the food-born fusariotoxins Enniatin B and Beauvericin. Toxicol Lett. 2016 Apr 15;247:35-44.
Cas No. | 917-13-5 | SDF | |
Synonyms | Antibiotic 86/88 | ||
Chemical Name | cyclo[(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl | ||
Canonical SMILES | O=C(O[C@H](C(C)C)C(N([C@H](C(O[C@@H](C(N([C@H](C(O[C@@H]1C(C)C)=O)C(C)C)C)=O)C(C)C)=O)C(C)C)C)=O)[C@H](C(C)C)N(C)C1=O | ||
Formula | C33H57N3O9 | M.Wt | 639.8 |
Solubility | DMF: Soluble,DMSO: Soluble,Ethanol: Soluble,Methanol: Soluble | Storage | Store at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Prepare stock solution | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 1.563 mL | 7.8149 mL | 15.6299 mL |
5 mM | 0.3126 mL | 1.563 mL | 3.126 mL |
10 mM | 0.1563 mL | 0.7815 mL | 1.563 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5
(Based on Reviews and 23 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *